Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart Reid

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Paediatrics and Child Health|October 15, 2011
Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemicDiana Lennon, Stewart Reid, Joanna Stewart, et al.
Vaccine|March 10, 2005
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strainPhilipp Oster, Diana Lennon, Jane O'Hallahan, et al.
Vaccine|January 12, 2008
The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New ZealandPaul Stehr-Green, Sarah Radke, Charlotte Kieft, et al.
The New Zealand Medical Journal|October 16, 2004
Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New ZealandKerry Sexton, Diana Lennon, Philipp Oster, et al.
The New Zealand Medical Journal|February 12, 2008
Human papilloma virus vaccines and their role in cancer preventionRonald W Jones, Edward P Coughlan, J Stewart Reid, et al.
BMC Health Services Research|May 4, 2012
Impact of organizational factors on adherence to laboratory testing protocols in adult HIV care in Lusaka, ZambiaSarang Deo, Stephanie M Topp, Andrew O Westfall, et al.
Archives of Disease in Childhood|May 21, 2011
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlersCatherine Jackson, Diana Lennon, Sharon Wong, et al.
Vaccine|March 10, 2005
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal diseaseJane O'Hallahan, Diana Lennon, Philipp Oster, et al.
The New Zealand Medical Journal|October 12, 2004
The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemicKerry Sexton, Diana Lennon, Philipp Oster, et al.
Vaccine|April 24, 2008
The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New ZealandMichael V Tatley, Desireé L Kunac, Anne McNicholas, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Paediatrics and Child Health|October 15, 2011
Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemicDiana Lennon, Stewart Reid, Joanna Stewart, et al.
Vaccine|March 10, 2005
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strainPhilipp Oster, Diana Lennon, Jane O'Hallahan, et al.
Vaccine|January 12, 2008
The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New ZealandPaul Stehr-Green, Sarah Radke, Charlotte Kieft, et al.
The New Zealand Medical Journal|October 16, 2004
Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New ZealandKerry Sexton, Diana Lennon, Philipp Oster, et al.
The New Zealand Medical Journal|February 12, 2008
Human papilloma virus vaccines and their role in cancer preventionRonald W Jones, Edward P Coughlan, J Stewart Reid, et al.
BMC Health Services Research|May 4, 2012
Impact of organizational factors on adherence to laboratory testing protocols in adult HIV care in Lusaka, ZambiaSarang Deo, Stephanie M Topp, Andrew O Westfall, et al.
Archives of Disease in Childhood|May 21, 2011
Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlersCatherine Jackson, Diana Lennon, Sharon Wong, et al.
Vaccine|March 10, 2005
From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal diseaseJane O'Hallahan, Diana Lennon, Philipp Oster, et al.
The New Zealand Medical Journal|October 12, 2004
The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemicKerry Sexton, Diana Lennon, Philipp Oster, et al.
Vaccine|April 24, 2008
The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New ZealandMichael V Tatley, Desireé L Kunac, Anne McNicholas, et al.
Pageof 4